Moody’s Investors Service on Friday raised the outlook on Amgen Inc. to positive from stable and affirmed its A3 long-term rating – MW
Risk Our Money Not Yours | Get 50% Off Any Account
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply